Tactile Systems Technology Inc (NASDAQ:TCMD) COO Robert J. Folkes sold 1,500 shares of the business’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $30.48, for a total transaction of $45,720.00. Following the transaction, the chief operating officer now owns 118,277 shares in the company, valued at approximately $3,605,082.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of Tactile Systems Technology Inc (NASDAQ TCMD) opened at $31.13 on Monday. Tactile Systems Technology Inc has a one year low of $15.92 and a one year high of $37.88. The stock has a market cap of $551.06, a price-to-earnings ratio of 207.53, a PEG ratio of 6.97 and a beta of -0.23.
A number of research analysts recently issued reports on TCMD shares. Canaccord Genuity reiterated a “buy” rating and set a $37.00 target price on shares of Tactile Systems Technology in a research report on Wednesday, January 3rd. BidaskClub upgraded shares of Tactile Systems Technology from a “sell” rating to a “hold” rating in a research report on Thursday, December 14th. Sidoti started coverage on shares of Tactile Systems Technology in a research note on Friday, December 8th. They set a “neutral” rating for the company. Zacks Investment Research upgraded shares of Tactile Systems Technology from a “hold” rating to a “strong-buy” rating and set a $28.00 price target for the company in a research note on Friday, November 10th. Finally, BTIG Research upgraded shares of Tactile Systems Technology from a “neutral” rating to a “buy” rating in a research note on Thursday, November 9th. They noted that the move was a valuation call. Four research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $34.25.
About Tactile Systems Technology
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.